The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Small intestinal bacterial overgrowth in Parkinson's disease
Abstract
Background Recent studies reported a high prevalence of small intestinal bacterial overgrowth (SIBO) in Parkinson's disease (PD), and a possible association with gastrointestinal symptoms and worse motor function. We aimed to study the prevalence and the potential impact of SIBO on gastrointestinal symptoms, motor function, and quality of life in a large cohort of PD patients.Methods 103 Consecutive PD patients were assessed using the lactulose-hydrogen breath test; questionnaires of gastrointestinal symptoms and quality of life (PDQ-39); the Unified PD Rating Scale (UPDRS) including "on"-medication Part III (motor severity) score; and objective and quantitative measures of bradykinesia (Purdue Pegboard and timed test of gait). Patients and evaluating investigators were blind to SIBO status.Results 25.3% of PD patients were SIBO-positive. SIBO-positive patients had a shorter mean duration of PD (5.2 ± 4.1 vs. 8.1 ± 5.5 years, P = 0.007). After adjusting for disease duration, SIBO was significantly associated with lower constipation and tenesmus severity scores, but worse scores across a range of "on"-medication motor assessments (accounting for 4.2-9.0% of the variance in motor scores). There was no association between SIBO and motor fluctuations or PDQ-39 Summary Index scores.Conclusions This is the largest study to date on SIBO in PD. SIBO was detected in one quarter of patients, including patients recently diagnosed with the disease. SIBO was not associated with worse gastrointestinal symptoms, but independently predicted worse motor function. Properly designed treatment trials are needed to confirm a causal link between SIBO and worse motor function in PD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“PD patients suffering from SIBO were not reported to develop worse GI dysfunction.”
From The Gut-Brain Axis in Parkinson’s Disease: Possibilities for Food-Based Therapies (2017) · cites this paper as Tan et al., 2014
In the citing paper
“Abnormalities of GI motility might increase the occurrence of SIBO which is highly prevalent in PD patients (Brown et al., 2011;Sánchez-Ferro et al., 2015), even in recently diagnosed PD patients (Tan et al., 2014).”
From The Gut-Brain Axis in Parkinson’s Disease: Possibilities for Food-Based Therapies (2017) · cites this paper as Tan et al., 2014
In the citing paper
“However, they were independently predisposed to worse motor-dysfunction (Tan et al., 2014).”
From The Gut-Brain Axis in Parkinson’s Disease: Possibilities for Food-Based Therapies (2017) · cites this paper as Tan et al., 2014
In the citing paper
“As mentioned before, SIBO is highly prevalent in PD (Andrews et al., 2009;Brown et al., 2011) and PD patients that tested positive for SIBO are predisposed to worse motordysfunction (Tan et al., 2014).”
From The Gut-Brain Axis in Parkinson’s Disease: Possibilities for Food-Based Therapies (2017) · cites this paper as Tan et al., 2014
Citations
Cites
Gastrointestinal Dysfunction in Parkinson’s Disease
Fasano, A., Visanji, N. P., Liu, L. W. C., Lang, A. E., & Pfeiffer, R. F. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00007-1 · Cited by 1,016
Forsyth, C. B., Shannon, K. M., Kordower, J. H., Voigt, R. M., Shaikh, M., Jaglin, J. A., Estes, J. D., Dodiya, H. B., & Keshavarzian, A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028032 · Cited by 974
Small intestinal bacterial overgrowth syndrome
Bures, J. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i24.2978 · Cited by 620
The impact of systemic infection on the progression of neurodegenerative disease
Perry, V. H., Newman, T. A., & Cunningham, C. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1032 · Cited by 428
Nutl, J. G., & Fellman, J. H. (1984) · Clinical Neuropharmacology · doi:10.1097/00002826-198403000-00002 · Cited by 357
Increased Incidence of Small Intestinal Bacterial Overgrowth During Proton Pump Inhibitor Therapy
Lombardo, L., Foti, M., Ruggia, O., & Chiecchio, A. (2010) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2009.12.022 · Cited by 350
The role of small intestinal bacterial overgrowth in Parkinson's disease
Fasano, A., Bove, F., Gabrielli, M., Petracca, M., Zocco, M. A., Ragazzoni, E., Barbaro, F., Piano, C., Fortuna, S., Tortora, A., et al. (2013) · Movement Disorders · doi:10.1002/mds.25522 · Cited by 344
Small Intestinal Bacterial Overgrowth: Roles of Antibiotics, Prebiotics, and Probiotics
Quigley, E. M. M., & Quera, R. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.11.046 · Cited by 330
A Systematic Review of Diagnostic Tests for Small Intestinal Bacterial Overgrowth
Khoshini, R., Dai, S.-C., Lezcano, S., & Pimentel, M. (2008) · Digestive Diseases and Sciences · doi:10.1007/s10620-007-0065-1 · Cited by 323
Small intestinal bacterial overgrowth: a comprehensive review.
(2007) · PubMed Central · Cited by 321
Gastrointestinal dysfunction in Parkinson's disease
Pfeiffer, R. F. (2011) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2010.08.003 · Cited by 298
The Relationship of Parkinson Disease With Aging
Levy, G. (2007) · Archives of Neurology · doi:10.1001/archneur.64.9.1242 · Cited by 251
Lymphocyte populations in Parkinson's disease and in rat models of parkinsonism
Bas, J. (2001) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(00)00422-7 · Cited by 250
Gastrointestinal dysfunction in Parkinson's Disease
Jost, W. H. (2010) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.08.020 · Cited by 222
Overview of the Extranigral Aspects of Parkinson Disease
Lim, S., Fox, S. H., & Lang, A. E. (2009) · Archives of Neurology · doi:10.1001/archneurol.2008.561 · Cited by 207
Reduced T helper and B lymphocytes in Parkinson's disease
Stevens, C. H., Rowe, D. B., Morel‐Kopp, M., Orr, C., Russell, T., Ranola, M., Wård, C., & Halliday, G. M. (2012) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2012.07.015 · Cited by 200
Helicobacter pylori eradication and l-dopa absorption in patients with PD and motor fluctuations
Pierantozzi, M., Pietroiusti, A., Brusa, L., Galati, S., Stefani, A., Lunardi, G., Fedele, E., Sancesario, G., Bernardi, G., Bergamaschi, A., et al. (2006) · Neurology · doi:10.1212/01.wnl.0000221672.01272.ba · Cited by 199
Gastrointestinal Motility Problems in Patients with Parkinsonʼs Disease
Jost, W. H. (1997) · Drugs & Aging · doi:10.2165/00002512-199710040-00002 · Cited by 177
Prevalence of small intestinal bacterial overgrowth in Parkinson’s disease
Gabrielli, M., Bonazzi, P., Scarpellini, E., Bendia, E., Lauritano, E. C., Fasano, A., Ceravolo, M. G., Capecci, M., Rita Bentivoglio, A., Provinciali, L., et al. (2011) · Movement Disorders · doi:10.1002/mds.23566 · Cited by 175
Small intestinal bacterial overgrowth
Rana, S., & Bhardwaj, S. B. (2008) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520801947074 · Cited by 141
Diagnosis and Management of Small Intestinal Bacterial Overgrowth
Bohm, M. E., Siwiec, R. M., & Wo, J. M. (2013) · Nutrition in Clinical Practice · doi:10.1177/0884533613485882 · Cited by 123
Parlesak, A., Klein, B., Schecher, K., Bode, J., & Bode, C. (2003) · Journal of The American Geriatrics Society · doi:10.1046/j.1365-2389.2003.51259.x · Cited by 108
Intestinal Permeability and Orocaecal Transit Time in Elderly Patients with Parkinson’s Disease
Davies, K. N., King, D., Billington, D., & Barrett, J. A. (1996) · Postgraduate Medical Journal · doi:10.1136/pgmj.72.845.164 · Cited by 88
Furnari, M., Parodi, A., Gemignani, L., Giannini, E. G., Marenco, S., Savarino, E. V., Assandri, L., Fazio, V., Bonfanti, D., Inferrera, S., et al. (2010) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2010.04436.x · Cited by 86
Dobbs, S. M., Dobbs, R. J., Weller, C., Charlett, A., Bjarnason, I., Lawson, A., Letley, D. P., Harbin, L. J., Price, A. B., Ibrahim, M. A. A., et al. (2010) · Helicobacter · doi:10.1111/j.1523-5378.2010.00768.x · Cited by 75
Bate, J. P., Irving, P. M., Barrett, J. S., & Gibson, P. R. (2010) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e32832b20e8 · Cited by 72
Lactose malabsorption in the elderly: Role of small intestinal bacterial overgrowth
Almeida, J. A., Kim, R., Stoita, A., McIver, C. J., Kurtovic, J., & Riordan, S. M. (2008) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520701676617 · Cited by 62
Dobbs, R. J., Charlett, A., Dobbs, S. M., Weller, C., Ibrahim, M. A. A., Iguodala, O., Smee, C., Plant, J., Lawson, A., Taylor, D. M., et al. (2012) · Gut Pathogens · doi:10.1186/1757-4749-4-12 · Cited by 54
Dobbs, S. M., Charlett, A., Dobbs, R. J., Weller, C., Iguodala, O., Smee, C., Lawson, A., Taylor, D. M., & Bjarnason, I. (2013) · Helicobacter · doi:10.1111/hel.12035 · Cited by 36
Diagnosis of small intestinal bacterial overgrowth: the challenges persist!
Abu-Shanab, A., & Quigley, E. M. M. (2009) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.3.1.77 · Cited by 35
Gibson, P. R., & Barrett, J. S. (2010) · Nutrition · doi:10.1016/j.nut.2010.01.005 · Cited by 34
Beyond here be dragons: SIBO in Parkinson's disease
Pfeiffer, R. F. (2013) · Movement Disorders · doi:10.1002/mds.25705 · Cited by 22
SMALL-INTESTINAL TRANSIT TIME IN THE ELDERLY
Haboubi, N. Y., Hudson, P. R., Rahman, Q., Lee, G. S., & Ross, A. (1988) · The Lancet · doi:10.1016/s0140-6736(88)91732-1 · Cited by 18
Parkinson disease clinical subtypes and their implications
Schapira, A. H. V., & Schrag, A. E. (2011) · Nature Reviews Neurology · doi:10.1038/nrneurol.2011.40 · Cited by 17
Cited by
Sorted by citations
Non-motor features of Parkinson disease
Schapira, A. H. V., Chaudhuri, K. R., & Jenner, P. (2017) · Nature Reviews Neuroscience · doi:10.1038/nrn.2017.62 · Cited by 2,053
Colonic bacterial composition in Parkinson's disease
Keshavarzian, A., Green, S. J., Engen, P. A., Voigt, R. M., Naqib, A., Forsyth, C. B., Mutlu, E., & Shannon, K. M. (2015) · Movement Disorders · doi:10.1002/mds.26307 · Cited by 1,281
Gastrointestinal Dysfunction in Parkinson’s Disease
Fasano, A., Visanji, N. P., Liu, L. W. C., Lang, A. E., & Pfeiffer, R. F. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00007-1 · Cited by 1,016
The gut-brain axis: is intestinal inflammation a silent driver of Parkinson’s disease pathogenesis?
Houser, M. C., & Tansey, M. G. (2017) · npj Parkinson's Disease · doi:10.1038/s41531-016-0002-0 · Cited by 588
Brain-Gut-Microbiota Axis in Parkinson’s Disease
Mulak, A. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i37.10609 · Cited by 583
Metadata
- Authors
- Tan, A. H., Mahadeva, S., Thalha, A. M., Gibson, P. R., Kiew, C. K., Yeat, C. M., Ng, S. W., Ang, S. P., Chow, S. K., Tan, C. T., Yong, H. S., Marras, C., Fox, S. H., & Lim, S.-Y.
- Affiliations
- University of Malaya (MY)
- The Alfred Hospital (AU)
- University of Toronto (CA)
- Corresponding author
- Lim, Shen-Yang
- ORCID
- Venue
- Parkinsonism & Related Disorders
- Publisher
- Elsevier BV
- Published
- 2014-05
- Volume
- 20
- Issue
- 5
- Pages
- 535-540
- ISSN
- 1353-8020 (ISSN-L)
- OpenAlex
- W1983564695
- Cited by
- 274
- References
- 34
- Citations by year
- 2026: 8 · 2025: 19 · 2024: 21 · 2023: 24 · 2022: 29 · 2021: 39 · 2020: 34 · 2019: 25 · 2018: 28 · 2017: 20 · 2016: 11 · 2015: 15 · 2014: 1
- FWCI
- 10.21
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Parkinsonism & Related Disorders (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Malaysian Ministry of Higher Education
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Keywords
- small intestinal bacterial overgrowth, Parkinson's disease
- MeSH terms
- Aged, Bacterial Infections, Female, Humans, Hydrogen, Intestinal Diseases, Lactulose, Male, Middle Aged, Parkinson Disease, Quality of Life, Surveys and Questionnaires, Regression Analysis, Severity of Illness Index, Prevalence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review